公司資料
Surface Oncology 股價、新聞與催化劑
- 股票代碼:
- SURF
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for SURF.
公司概覽
業務概覽
Surface Oncology was an immuno-oncology company focused on antibody-based cancer therapies before its restructuring and decline. Its platform centered on immune checkpoints and tumor biology.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, Surface sat in oncology biotechnology.
商業模式特徵
The business depended on clinical validation, platform differentiation, and the ability to create oncology value.
生技產業定位
Surface belongs to the historical oncology-biotech category rather than the current live public-company set.
未來催化劑
- Surface Oncology is now largely a closeout story, with catalysts limited to any strategic or asset-disposition update. Investors are mainly watching what residual value can be realized.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。